Our top pick for
Spok Holdings Inc is a telecom services business based in the US. Spok shares (SPOK) are listed on the NASDAQ and all prices are listed in US Dollars. Spok employs 590 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$10.09|
|52-week range||$7.16 - $12.38|
|50-day moving average||$10.13|
|200-day moving average||$9.83|
|Wall St. target price||$7.00|
|Dividend yield||$0.5 (4.95%)|
|Earnings per share (TTM)||$-2.43|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-20)||-1.37%|
|1 month (2021-09-27)||-0.10%|
|3 months (2021-07-27)||12.61%|
|6 months (2021-04-27)||-4.99%|
|1 year (2020-10-26)||12.11%|
|2 years (2019-10-25)||-10.87%|
|3 years (2018-10-26)||14.17|
|5 years (2016-10-26)||17.04|
Valuing Spok stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Spok's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Spok's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $6.6 million.
The EBITDA is a measure of a Spok's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$146.9 million|
|Gross profit TTM||$103.4 million|
|Return on assets TTM||-0.01%|
|Return on equity TTM||-21.09%|
|Market capitalisation||$198.2 million|
TTM: trailing 12 months
There are currently 636,190 Spok shares held short by investors – that's known as Spok's "short interest". This figure is 4.2% down from 664,111 last month.
There are a few different ways that this level of interest in shorting Spok shares can be evaluated.
Spok's "short interest ratio" (SIR) is the quantity of Spok shares currently shorted divided by the average quantity of Spok shares traded daily (recently around 355413.40782123). Spok's SIR currently stands at 1.79. In other words for every 100,000 Spok shares traded daily on the market, roughly 1790 shares are currently held short.
However Spok's short interest can also be evaluated against the total number of Spok shares, or, against the total number of tradable Spok shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Spok's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Spok shares in existence, roughly 30 shares are currently held short) or 0.0431% of the tradable shares (for every 100,000 tradable Spok shares, roughly 43 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Spok.
Find out more about how you can short Spok stock.
We're not expecting Spok to pay a dividend over the next 12 months.
Over the last 12 months, Spok's shares have ranged in value from as little as $7.16 up to $12.3815. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Spok's is 0.2481. This would suggest that Spok's shares are less volatile than average (for this exchange).
Spok Holdings, Inc. , through its subsidiary, Spok, Inc. , provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. It offers Spok Healthcare Console that helps operators perform directory searches and code calls, as well as messaging and paging; Spok Web-Based Directory that enables staff to send messages from the directory; Spok Web-Based On-Call Scheduling, which keeps personnel, calendars, and on-call scheduling information updated; Spok Speech to process routine phone requests, including transfers, directory assistance, messaging, and paging; and Spok Call Recording and Quality Management, which records, monitors, and scores operators' conversations. The company also provides Spok Mobile for secure code alerts, patient updates, results, consult requests, and other services; Spok Device Preference Engine, which facilitates voice conversations among doctors and caregivers; Spok pc/psap that integrates the phone system, mapping systems, and other resources to speed emergency dispatch; and Spok Enterprise Alert, which directs emergency personnel to caller's location. In addition, it sells devices to resellers who lease or resell them to their subscribers; and ancillary services, such as voicemail and equipment loss or maintenance protection, as well as provides a suite of professional services, and software license updates and product support services. The company serves businesses, professionals, management personnel, medical personnel, field sales personnel and service forces, members of the construction industry and construction trades, real estate brokers and developers, sales and services organizations, specialty trade organizations, manufacturing organizations, and government agencies.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.